| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50071 |
MDCK (NBL-2) |
dog |
kidney |
Epitherial-like cell line established from normal kidney of dog, susceptible for many viral species. |
|
| 2 | general cells |
IFO50412 |
CCRF-CEM |
human |
peripheral blood |
leukemia, acute T lymphoblastic |
|
| 3 | general cells |
IFO50518 |
KAI3 |
human |
peripheral blood |
EBV-infected NK-like cell line, IL-2 dependent |
|
| 4 | general cells |
JCRB0129.2 |
RCR-1.P3 |
rat |
brain |
Rat astrocyte-like cell line prducing GFAP in serum free cell culture. Parental strain of this cell line is also available(JCRB0129.1). |
|
| 5 | general cells |
JCRB0834 |
NUGC-4 |
human |
gastric lymph node |
adenocarcinoma, poorly differentiated, signet ring cell carcinoma |
|
| 6 | general cells |
JCRB1064 |
KYSE110 |
human |
esophagus |
Poorly differentiated squamous carcinoma cell line from human esophagus cancer. |
|
| 7 | general cells |
JCRB1104 |
cs-20-5 |
hamster, Chinese |
lung |
temperature sensitive mutant of Chinese hamster lung cell line. |
|
| 8 | general cells |
JCRB1145 |
HEC-50B |
human |
peritoneal fluid |
Human endometrioid adenocarcinoma (G3) from japanese patient. |
|
| 9 | general cells |
JCRB1354 |
HSC-3-M3 |
human |
tongue |
Highly metastatic cell line to lymph node in human oral squamous cell carcinoma derived from the HSC-3. |
|
| 10 | genetically-modified cells |
JCRB1371 |
GS-3A4-HepG2 |
human |
Liver |
Human glutamine synthetase gene and drug-metabolizing CYP3A4 gene introduced Hep G2 cells. |
|
| 11 | general cells |
JCRB1421 |
KYSE1190 |
human |
esophagus |
Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 12 | general cells |
JCRB1434 |
KYSE1260 |
human |
esophagus |
Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 13 | general cells |
JCRB1452 |
KYSE2780 |
human |
esophagus |
Human squamous cell carcinoma cell line established from esophageal cancer. |
|
| 14 | general cells |
JCRB1467 |
KYSE2710 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 15 | general cells |
JCRB1469 |
KYSE2880 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 16 | genetically-modified cells |
JCRB1533 |
293 TRE/Cont |
human |
kidney |
Control 293 cell line for 293 TRE/FLAG-POLK. |
|
| 17 | genetically-modified cells |
JCRB1535 |
TBK1-DEF |
mouse |
embryo |
Mouse embryonic fibroblasts prepared from TANK-binding kinase 1 (TBK1) deficient mice. |
|
| 18 | general cells |
JCRB1613 |
hTf26-9B |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
| 19 | general cells |
JCRB1796 |
BALM-18 |
human |
peripheral blood |
B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;14)(q24;q32) |
|
| 20 | general cells |
JCRB4172 |
NCC-CCS1B-C1 |
human |
Left thigh |
Clear cell sarcoma cell line (Establish from biopsy sample) |
|
| 21 | general cells |
JCRB9045 |
Detroit 539 |
human |
skin |
Down's syndrome, skin |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.